Why the study?
Do platelets from patients with pulmonary hypertension exhibit altered bioenergetics compared to healthy controls?
Population
56 subjects, comprising 28 patients with WHO Group 1 pulmonary hypertension and 28 healthy age- and…
Design
Case-control
Authors
Loading...
Suggests platelet bioenergetics may serve as a biomarker for pulmonary hypertension severity; leaves.
Do platelets from patients with pulmonary hypertension exhibit altered bioenergetics compared to healthy controls?
Platelets from pulmonary hypertension patients exhibit increased glycolysis and enhanced respiratory reserve capacity driven by fatty acid oxidation, which correlates with hemodynamic severity.
Nguyen et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: